EMRI Financials 07/16/2014 04:15:50 Emrise Corp.

EMRI Financials 07/16/2014 04:15:50
Emrise Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 31,898 34,047 33,531 29,523
Cost of Revenue 22,183 24,041 24,007 20,642
Gross Profit 9,715 10,006 9,524 8,881
Operating Expenses
Research and Development 1,132 1,267 1,549 1,730
Sales, General and Admin. 8,334 8,794 9,618 10,926
Non-Recurring Items - - - -
Other - - - -
Operating Income 249 (55) (1,643) (3,775)
Income From Continuing Operations
Add'l Income/Expense Items 5 860 66 401
Earnings Before Interest and Tax 254 805 (1,577) (3,374)
Interest Expense 534 388 383 1,940
Earnings Before Tax (280) 417 (1,960) (5,314)
Income Tax 112 314 88 583
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (392) 103 (2,048) (5,897)
Non Recurring Events
Discontinued Operations - (9) 429 2,476
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (392) 94 (1,619) (3,421)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (392) 94 (1,619) (3,421)